Search clinical trials for: mTOR inhibitor (everolimus)
Total 65474 results
-
Novartis PharmaceuticalsCompletedGrowth and DevelopmentBelgium, United States, Russian Federation
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Recruiting
-
NCIC Clinical Trials GroupCompleted
-
Novartis PharmaceuticalsCompletedPancreatic Neuroendocrine TumorsChina
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Novartis; Dana-Farber Cancer InstituteCompletedNeuroendocrine TumorsUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedSystemic MastocytosisUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingKidney CancerUnited States, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, Belgium, Taiwan, Turkey, Australia, Korea, Republic of, Thailand, France, Hungary, United Kingdom, Italy, Japan, Canada, Russian Federation, Poland, Mexico, Colombia
-
Johns Hopkins UniversityActive, not recruiting
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsTerminatedNeuroma, Acoustic | Neurofibromatosis Type 2United States
-
A. Manzoni HospitalTerminated
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaSpain, Canada, Portugal, Korea, Republic of, Taiwan, United States, Netherlands, United Kingdom, Czechia, Italy, Finland, Greece, Romania, Australia, Poland, Russian Federation
-
University Hospital, Strasbourg, FranceActive, not recruitingBK Virus Nephropathy After Kidney TransplantationFrance
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingThyroid CancerUnited States
-
Peking University First HospitalRecruitingRenal Cell Carcinoma, Clear Cell, SomaticChina
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery OcclusionJapan
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
Fudan UniversityRecruitingKidney Cancer | Renal Cell Carcinoma | Renal Clear Cell CarcinomaChina
-
Abbott Medical DevicesActive, not recruitingCoronary Artery DiseaseUnited States, Spain, France
-
Hannover Medical SchoolUnknownVirus Diseases | Disorder Related to Renal Transplantation | Immunosuppression Related Infectious DiseaseGermany
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedLiver Metastases | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | SomatostatinomaUnited States
-
NCIC Clinical Trials GroupCompletedBrain and Central Nervous System TumorsCanada
-
Hutchison Medipharma LimitedRecruitingAdvanced Renal Cell CarcinomaChina
-
University of California, San FranciscoNovartis Pharmaceuticals; Pacific Pediatric Neuro-Oncology Consortium; The Pediatric...Active, not recruitingPediatric Recurrent Progressive Low-grade Gliomas | Pediatric Progressive Low-grade GliomasUnited States
-
Seung-Jung ParkAbbott Medical Devices; CardioVascular Research Foundation, KoreaTerminatedCoronary Artery DiseaseThailand, Korea, Republic of, China, Malaysia
-
The University of Texas Health Science Center,...Texas Neurofibromatosis FoundationCompletedNeurofibromatosis 1United States
-
Gruppo Oncologico Italiano di Ricerca ClinicaNovartisActive, not recruitingNeuroendocrine CarcinomaItaly
-
Boston Scientific CorporationActive, not recruiting
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
Josep M CruzadoTerminatedMuscle Strength | Disorder Related to Renal Transplantation | Exercise, AerobicSpain
-
Novartis PharmaceuticalsCompleted
-
Fudan UniversityAnyang Tumor HospitalNot yet recruiting
-
Novartis PharmaceuticalsRecruiting
-
University of Texas Southwestern Medical CenterCompletedRecurrent Childhood EpendymomaUnited States
-
UNICANCERMinistry of Health, FranceActive, not recruitingPrimary Non-metastatic Breast Cancer | Who Remain Disease-freeFrance
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
CoImmuneTerminatedAdvanced Renal Cell CarcinomaUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Verastem, Inc.; Chugai PharmaceuticalRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Solid TumoursUnited Kingdom
-
Shanghai MicroPort Medical (Group) Co., Ltd.CompletedCoronary Artery DiseaseDenmark
-
M.D. Anderson Cancer CenterNovartisActive, not recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Norway
-
Nationwide Children's HospitalNovartisNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
University of PennsylvaniaActive, not recruiting
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedRecurrent and Refractory Solid TumorsUnited States, Canada